TGTX, MULN and EFOI among pre market gainers
franckreporter/iStock via Getty Images
- Turning Point Therapeutics TPTX +116% Bristol Myers to acquire Turning Point Therapeutics for over $4B in cash.
- The Marygold Companies (MGLD) +32%.
- Energy Focus (EFOI) +26%.
- Amylyx Pharmaceuticals AMLX +23% as FDA extends review period of ALS drug which failed panel backing.
- Sprague Resources SRLP +20% to be taken private by Hartree Partners for $19/unit.
- Okta OKTA +15% on Q1 results.
- StoneCo STNE +12% on Q1 results.
- Society Pass SOPA +11% on acquisition of Singapore-based Gorilla Networks.
- CN Energy (CNEY) +9%.
- Mullen Automotive (MULN) +7%.
- Chegg CHGG +7% on additional $1B buyback authorization.
- Redbox Entertainment (RDBX) +6%.
- Applied Therapeutics APLT +5% on EMA orphan drug status for metabolic disorder drug AT-007.
- TG Therapeutics (TGTX) +6%.